Helen Leather

3.5k total citations
49 papers, 2.3k citations indexed

About

Helen Leather is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Helen Leather has authored 49 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 20 papers in Infectious Diseases and 18 papers in Oncology. Recurrent topics in Helen Leather's work include Antifungal resistance and susceptibility (20 papers), Fungal Infections and Studies (17 papers) and Hematopoietic Stem Cell Transplantation (14 papers). Helen Leather is often cited by papers focused on Antifungal resistance and susceptibility (20 papers), Fungal Infections and Studies (17 papers) and Hematopoietic Stem Cell Transplantation (14 papers). Helen Leather collaborates with scholars based in United States, United Kingdom and Australia. Helen Leather's co-authors include John R. Wingard, Reuben Ramphal, Richard T. Maziarz, John F. DiPersio, Cornelius J. Clancy, L. Joseph Wheat, Paul Shaughnessy, Christina Cline, Lindsey R. Baden and Kieren A. Marr and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Helen Leather

47 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Leather United States 23 1.1k 1.1k 666 641 184 49 2.3k
Gerda Silling Germany 27 903 0.8× 920 0.8× 395 0.6× 587 0.9× 134 0.7× 49 1.8k
H. Gary Schoch United States 19 864 0.8× 985 0.9× 1.1k 1.7× 887 1.4× 392 2.1× 25 2.7k
Anna Candoni Italy 31 926 0.8× 955 0.9× 1.1k 1.7× 804 1.3× 391 2.1× 153 3.5k
Martin Schmidt‐Hieber Germany 26 509 0.5× 766 0.7× 567 0.9× 629 1.0× 102 0.6× 59 2.0k
David Bodensteiner United States 18 866 0.8× 771 0.7× 334 0.5× 363 0.6× 68 0.4× 35 1.7k
Nicole M. A. Blijlevens Netherlands 28 477 0.4× 589 0.5× 387 0.6× 711 1.1× 119 0.6× 75 2.1k
John Hiemenz United States 12 1.2k 1.0× 1.1k 1.0× 127 0.2× 1.1k 1.7× 142 0.8× 19 2.4k
Gloria Mattiuzzi United States 17 882 0.8× 896 0.8× 161 0.2× 356 0.6× 73 0.4× 36 1.4k
Axel Glasmacher Germany 39 1.7k 1.5× 1.8k 1.6× 906 1.4× 1.8k 2.9× 295 1.6× 117 4.7k
Ben de Pauw Netherlands 21 2.6k 2.4× 2.5k 2.3× 423 0.6× 1.1k 1.7× 133 0.7× 41 4.0k

Countries citing papers authored by Helen Leather

Since Specialization
Citations

This map shows the geographic impact of Helen Leather's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Leather with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Leather more than expected).

Fields of papers citing papers by Helen Leather

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Leather. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Leather. The network helps show where Helen Leather may publish in the future.

Co-authorship network of co-authors of Helen Leather

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Leather. A scholar is included among the top collaborators of Helen Leather based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Leather. Helen Leather is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wingard, John R., Ji‐Hyun Lee, Zeina Al‐Mansour, et al.. (2025). Randomized Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem-Cell Transplant Patients and Patients With Acute Leukemia. Journal of Clinical Oncology. 44(4). 300–310.
2.
Farhadfar, Nosha, Helen Leather, Shu Wang, et al.. (2021). Severity of Acute Graft-Versus-Host Disease and Associated Healthcare Resource Utilization, Cost and Outcomes. Transplantation and Cellular Therapy. 27(3). S23–S23. 1 indexed citations
3.
Farhadfar, Nosha, Helen Leather, Shu Wang, et al.. (2021). Severity of Acute Graft-versus-Host Disease and Associated Healthcare Resource Utilization, Cost, and Outcomes. Transplantation and Cellular Therapy. 27(12). 1007.e1–1007.e8. 7 indexed citations
4.
Drusbosky, Leylah, Kimberly E. Hawkins, Glenda G. Anderson, et al.. (2018). iCare 1: A prospective clinical trial to predict treatment response based on genomics-informed computational biology in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).. Journal of Clinical Oncology. 36(15_suppl). 7024–7024.
5.
7.
Bubalo, Joseph, Paul A. Carpenter, Navneet S. Majhail, et al.. (2014). Conditioning Chemotherapy Dose Adjustment in Obese Patients: A Review and Position Statement by the American Society for Blood and Marrow Transplantation Practice Guideline Committee. Biology of Blood and Marrow Transplantation. 20(5). 600–616. 51 indexed citations
8.
Duong, Hien K., Bipin N. Savani, Ed Copelan, et al.. (2014). Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 20(9). 1262–1273. 140 indexed citations
9.
Denzen, Ellen M., Navneet S. Majhail, Claudio Anasetti, et al.. (2012). Hematopoietic Cell Transplantation in 2020: Summary of Year 2 Recommendations of the National Marrow Donor Program's System Capacity Initiative. Biology of Blood and Marrow Transplantation. 19(1). 4–11. 29 indexed citations
10.
Nguyen, M. Hong, Helen Leather, Cornelius J. Clancy, et al.. (2010). Galactomannan Testing in Bronchoalveolar Lavage Fluid Facilitates the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Malignancies and Stem Cell Transplant Recipients. Biology of Blood and Marrow Transplantation. 17(7). 1043–1050. 58 indexed citations
11.
Schold, Jesse D., Shahab Khan, Helen Leather, et al.. (2009). Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT. Bone Marrow Transplantation. 45(1). 31–37. 1 indexed citations
12.
Husain, Shahid, Cornelius J. Clancy, M. Hong Nguyen, et al.. (2008). Performance Characteristics of the Platelia Aspergillus Enzyme Immunoassay for Detection of Aspergillus Galactomannan Antigen in Bronchoalveolar Lavage Fluid. Clinical and Vaccine Immunology. 15(12). 1760–1763. 73 indexed citations
13.
Clancy, Cornelius J., Helen Leather, John R. Wingard, et al.. (2007). Bronchoalveolar Lavage Galactomannan in Diagnosis of Invasive Pulmonary Aspergillosis among Solid-Organ Transplant Recipients. Journal of Clinical Microbiology. 45(6). 1759–1765. 160 indexed citations
14.
Leather, Helen & John R. Wingard. (2006). New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies. Blood Reviews. 20(5). 267–287. 23 indexed citations
15.
Williams, Casey, Suzanne Day, Michael D. Reed, et al.. (2004). Dose modification protocol using intravenous busulfan (Busulfex) and cyclophosphamide followed by autologous or allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Biology of Blood and Marrow Transplantation. 10(9). 614–623. 26 indexed citations
16.
Leather, Helen. (2003). Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know. Bone Marrow Transplantation. 33(2). 137–152. 38 indexed citations
17.
Leather, Helen & John R. Wingard. (2002). Prophylaxis, empirical therapy, or pre-emptive therapy of fungal infections in immunocompromised patients: which is better for whom?. Current Opinion in Infectious Diseases. 15(4). 369–375. 15 indexed citations
18.
Mainwaring, Mark, Lisa M. Rimsza, SF Chen, et al.. (2002). Treatment of Refractory Acute Leukemia with Timed Sequential Chemotherapy Using Topotecan Followed by Etoposide+Mitoxantrone (T-EM) and Correlation with Topoisomerase II Levels. Leukemia & lymphoma. 43(5). 989–999. 12 indexed citations
19.
Zumberg, Marc, et al.. (2002). GM-CSF versus G-CSF: engraftment characteristics, resource utilization, and cost following autologous PBSC transplantation. Cytotherapy. 4(6). 531–538. 6 indexed citations
20.
Leather, Helen, et al.. (2001). Evolution, Incidence, and Susceptibility of Bacterial Bloodstream Isolates from 519 Bone Marrow Transplant Patients. Clinical Infectious Diseases. 33(7). 947–953. 221 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026